Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophreniaResearch in context

Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophreniaResearch in context

Summary: Background: People with schizophrenia differ in the type and severity of symptoms experienced, as well as their response to medication. A better understanding of the factors that influence this heterogeneity is necessary for the development of individualised patient care. Here, we sought t...

Full description

Saved in:
Bibliographic Details
Main Authors: Siobhan K. Lock, Djenifer B. Kappel, Michael J. Owen, James T.R. Walters, Michael C. O'Donovan, Antonio F. Pardiñas, Sophie E. Legge
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:EBioMedicine
Subjects:
Schizophrenia
Pharmacogenomics
Antipsychotics
Clozapine
Symptom severity
Cognition
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396425001896
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items